
|Articles|March 1, 2004
Rud's syndrome
Washington - Topical application of tazarotene 0.05 percent was effective in reducing cutaneous roughness and scaling in a patient with a rare form of ichthyosis known as Rud's syndrome, according to Maria Concetta Fargnoli, M.D., a dermatologist at the University of L'Aquila, Italy.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Harrison Nguyen, MD, MBA, MPH’s Deep Dive into CSU, Vasculitis, and Autoimmune Blisters
2
Day 3 Recap: SDPA Fall 2025
3
From TikTok to Targeted Therapy: Shannon Trotter, DO, on Modern Dermatology Challenges
4
Q&A: Why Oncologist-Dermatologist Collaboration is Essential for Managing Systemic Mastocytosis
5



















